Thermo Fisher Scientific Inc. Form 8-K Filing Summary

This Form 8-K filing details the proceedings of Thermo Fisher Scientific Inc.'s Annual Meeting held on May 20, 2026. Shareholders voted on several key proposals. All incumbent directors, including Marc N. Casper, Nelson J. Chai, Ruby R. Chandy, C. Martin Harris, Tyler Jacks, Jennifer M. Johnson, R. Alexandra Keith, Karen S. Lynch, Debora L. Spar, Scott M. Sperling, and Dion J. Weisler, were elected for a one-year term expiring at the 2027 annual meeting. However, a non-binding advisory proposal regarding the compensation of named executive officers did not receive majority approval. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified by the shareholders. The filing also lists various series of the company's notes and their respective due dates.